EA
CCXI

Emerald Acquisition’s ChemoCentryx, Inc. CCXI Stock Holding History

Emerald Acquisition’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$78K Sell
12,900
-21,600
-63% -$102K ﹤0.01% 2849
2016
Q2 		$155K Buy
+34,500
New +$129K ﹤0.01% 2775

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Emerald Acquisition's CCXI Position: Q3 2016 in Review

Emerald Acquisition reduced its ChemoCentryx, Inc. (CCXI) stake by 63% in Q3 2016, selling an estimated $102K and leaving 12,900 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #2849.

Emerald Acquisition first reported a position in CCXI in Q2 2016 and has held it in 2 quarters since. The position peaked at $155K in Q2 2016. 72 funds tracked by Wall St. Rank hold CCXI as of Q3 2016.

  • Emerald Acquisition held 12,900 shares of ChemoCentryx, Inc. worth $78K as of Q3 2016.
  • Emerald Acquisition sold 21,600 ChemoCentryx, Inc. shares in Q3 2016, an estimated $102K.
  • ChemoCentryx, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2849 holding.
  • Emerald Acquisition first reported a position in ChemoCentryx, Inc. in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's ChemoCentryx, Inc. position peaked at $155K in Q2 2016.
  • 72 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.